Thomas Chen, MD, PhD discussed his innovative approach to brain cancer treatment through NeOnc, Inc.
Thoman Chen, MD, PhD, Professor of Neurosurgery, Pathology, and Orthopedic Surgery at the Keck School of Medicine, University of Southern California discussed his work on a nasal delivery system. NeOnc, Inc. is developing innovative intranasal drug delivery methods to bypass the blood-brain barrier and treat brain cancers, including clinical trials for their lead candidate NEO100.
Thomas Chen, MD, PhD, has years of expertise in neurosurgery, spinal cancer, brain tumors, and medicine. Chen currently holds position of tenured Professor of Neurosurgery, Pathology, and Orthopedic Surgery at the Keck School of Medicine, University of Southern California. Chen is also the Founder and CEO of NeOnc, which focuses on developing therapeutics and drug delivery methods that treat central nervous system diseases and disorders.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Subscribe
